Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 13
Policy
Policy | 04 September 2021

Govt revises NLEM and slashes prices of 39 drugs

At present 18 per cent of the local pharmaceutical market is under government's price control

Policy
Policy | 02 September 2021

Union Minister Mansukh Mandaviya chairs meet on eradicating TB

Coordinated and collaborative efforts will strongly contribute to the achievement of shared goals faster: Mandaviya

Policy
Policy | 01 September 2021

WHO releases compendium of innovative health technologies

The Covid-19 pandemic has exposed the divide that exists between rich and developing nations and to address these challenges the World Health Organisation (WHO), has compiled a list of innovative health technologies that aim to bridge the gap

Policy
Policy | 30 August 2021

Union Minister Sonowal announces major plans for promoting Ayush in NE

A sum of Rs 70 crores and Rs 10 crores for a new Ayurvedic college in Assam and upgradation of the ayurvedic college in Guwahati respectively

Policy
Policy | 19 August 2021

Health Minister Mr Manshuk Madaviya launch Aarogya Dhara 2.0

The government plans to enrol over 50 crore people and empanel more hospitals under the scheme. The scheme provides a cover of Rs 5 lakh per family per year

Policy
Policy | 18 August 2021

Centre releases Rs 1,300 crores to Northeast states to fight Covid-19

The funds will be used to buy medicines, enhance oxygen supply and augment the bed capacity in the local and district level hospitals

Policy
Policy | 17 August 2021

Centre allocates Rs 267.35 crores to Kerala for Covid response

Rs one crore for each district to create medicine pool and support Centre of Excellence for Telemedicine

Policy
Policy | 16 August 2021

India restricts export of Rapid Antigen Test Kits used to detect Covid 19

The notification implies that any export of Rapid Antigen Kit will require a licence or permission from DGFT

Policy
Policy | 11 August 2021

NPPA has put a cap on the trade margin of 42 select non-scheduled anti-cancer medicines

A total of 526 brands has seen a reduction of up to 90 per cent in MRP

Policy
Policy | 09 August 2021

China NMPA approves phase II clinical trial of ASC40

Phase II trial will evaluate the safety and efficacy of ASC40 in patients with moderate to severe acne

Policy
Policy | 09 August 2021

Centre releases Rs. 60 crore to states seeking grants to tackle the Sickle Cell Anaemia

Sickle Cell Disease Support Corner developed to create a database of individuals with sickle cell disease

Policy
Policy | 06 August 2021

Govt augments PSEs and Bharat Biotech to ramp up Covaxin production

CDSCO to fast-track trials and approval for COVID19 vaccine

Policy
Policy | 05 August 2021

NPPA issues notice to manufacturers and importers of knee implants

The data should be submitted by August 12th 2021

Policy
Policy | 04 August 2021

India Initiates anti dumping probe against import of ATS-8 from China

Arch Pharma Labs has filed the application

Policy
Policy | 04 August 2021

Govt committed to recognise healthcare workers engaged in Covid-19

Five seats reserved for Wards of COVID warriors in central MBBS admission

Policy
Policy | 03 August 2021

PLI Scheme to generate export potential of Rs 196,000 crore by 2027 : Mandaviya

The scheme incentivizes the manufacturing of patented drugs and other high value drugs at an incentive rate of 10% of incremental sales

Policy
Policy | 03 August 2021

NPPA monitors and caps prices of essential drugs: Mandaviya

NPPA has capped the trade margin for Oxygen Concentrators at 70% on Price to Distributor (PTD) level

Policy
Policy | 03 August 2021

NPPA caps prices on five medical devices effective July 20th 2021

The highest reduction in prices for Pulse Oximeters, Blood Pressure Monitoring Machine and Nebulizer has been reported by importers

Policy
Policy | 03 August 2021

API exports surpass imports by value in 2020-21

The govt has rolled out three schemes for promoting the manufacture of API

Policy
Policy | 03 August 2021

Drug exports grow on the back of govt support

Drug formulations and biologics make impressive gains

Startup

Digitization